• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌病:概述。

Cardiomyopathy: An Overview.

机构信息

Saint Louis University, St. Louis, MO, USA.

出版信息

Am Fam Physician. 2017 Nov 15;96(10):640-646.

PMID:29431384
Abstract

The definition and classification of cardiomyopathy have evolved considerably in recent years. Cardiomyopathy can be separated into primary (genetic, mixed, or acquired) and secondary categories, which result in varied phenotypes including dilated, hypertrophic, and restrictive patterns. Hypertrophic cardiomyopathy is the most common primary cardiomyopathy and can cause exertional dyspnea, presyncope, atypical chest pain, heart failure, and sudden cardiac death. Dilated cardiomyopathy can be genetic or acquired and typically presents with classic symptoms of heart failure with reduced ejection fraction. Restrictive cardiomyopathy is much less common and often associated with systemic disease. Family physicians should be alert for acquired variants of cardiomyopathy, including peripartum and stress-induced cardiomyopathy, as well as rare variants, such as arrhythmogenic right ventricular dysplasia and left ventricular noncompaction. In addition to history and physical examination, diagnosis of cardiomyopathy includes electrocardiography and echocardiography testing. Treatment may include appropriately staged therapy for heart failure, appropriate activity restriction, evaluation for implantable cardioverter-defibrillator placement, and consideration of heart transplantation in refractory cases. Genetic testing of families is an emerging modality with some potential to augment traditional screening performed by family physicians.

摘要

近年来,心肌病的定义和分类发生了很大的变化。心肌病可分为原发性(遗传、混合或获得性)和继发性,导致不同的表型,包括扩张型、肥厚型和限制型。肥厚型心肌病是最常见的原发性心肌病,可导致运动时呼吸困难、晕厥前、非典型胸痛、心力衰竭和心源性猝死。扩张型心肌病可为遗传性或获得性,通常表现为射血分数降低的心力衰竭的典型症状。限制型心肌病则较为少见,常与系统性疾病相关。家庭医生应警惕获得性心肌病变异型,包括围产期和应激性心肌病,以及罕见的变异型,如致心律失常性右室心肌病和左室致密化不全。除了病史和体格检查,心肌病的诊断还包括心电图和超声心动图检查。治疗可能包括心力衰竭的分级治疗、适当的活动限制、评估植入式心脏复律除颤器的放置,以及在难治性病例中考虑心脏移植。对家族进行基因检测是一种新兴的方法,具有一定潜力增强家庭医生进行的传统筛查。

相似文献

1
Cardiomyopathy: An Overview.心肌病:概述。
Am Fam Physician. 2017 Nov 15;96(10):640-646.
2
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.致心律失常性右室心肌病 1 型相关蛋白基因突变致心肌病变的表型表达、自然病史和危险分层。
Circulation. 2021 Nov 16;144(20):1600-1611. doi: 10.1161/CIRCULATIONAHA.121.053521. Epub 2021 Sep 30.
3
[Clinical practice guidelines for hereditary cardiomyopathy].[遗传性心肌病临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):300-307. doi: 10.3760/cma.j.issn.1003-9406.2020.03.013.
4
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
5
Preoperative preparation of patients with cardiomyopathies in non-cardiac surgery.非心脏手术中心肌病患者的术前准备
Acta Chir Iugosl. 2011;58(2):39-43. doi: 10.2298/aci1102039b.
6
Primary cardiomyopathies: classification, pathophysiology, clinical recognition and management.原发性心肌病:分类、病理生理学、临床识别与管理
Cardiovasc Clin. 1980;10(3):199-230.
7
Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.非缺血性心肌病中的心脏性猝死:完善风险评估
J Cardiovasc Electrophysiol. 2017 Nov;28(11):1361-1366. doi: 10.1111/jce.13284. Epub 2017 Jul 26.
8
Cardiomyopathy: an overview.心肌病:概述。
Am Fam Physician. 2009 May 1;79(9):778-84.
9
[Current knowledge of cardiomyopathy].[心肌病的当前知识]
Med Pregl. 1997 Nov-Dec;50(11-12):481-5.
10
Congenital and hereditary causes of sudden cardiac death in young adults: diagnosis, differential diagnosis, and risk stratification.先天性和遗传性原因导致的年轻成年人心脏性猝死:诊断、鉴别诊断和风险分层。
Radiographics. 2013 Nov-Dec;33(7):1977-2001. doi: 10.1148/rg.337125073.

引用本文的文献

1
A novel gene variant c.525_533del causing Barth syndrome and leading to heart transplantation: a case report.一种导致巴特综合征并引发心脏移植的新型基因变异c.525_533del:病例报告
Front Pediatr. 2025 Aug 18;13:1634258. doi: 10.3389/fped.2025.1634258. eCollection 2025.
2
The cGAS/STING Pathway: Friend or Foe in Regulating Cardiomyopathy.cGAS/STING信号通路:调控心肌病的帮手还是敌人?
Cells. 2025 May 25;14(11):778. doi: 10.3390/cells14110778.
3
Effects of sodium-glucose cotransporter 2 inhibitors on cardiomyopathy: a meta-analysis.
钠-葡萄糖协同转运蛋白2抑制剂对心肌病的影响:一项荟萃分析。
J Endocrinol Invest. 2025 Jun 10. doi: 10.1007/s40618-025-02625-1.
4
Emerging role of the cGAS-STING pathway in cardiovascular diseases: biologic function, mechanisms and targeted therapy.cGAS-STING通路在心血管疾病中的新作用:生物学功能、机制及靶向治疗
Mol Med. 2025 Jun 4;31(1):218. doi: 10.1186/s10020-025-01273-8.
5
The role of deubiquitinases in cardiovascular diseases: mechanisms and therapeutic implications.去泛素化酶在心血管疾病中的作用:机制及治疗意义
Front Cardiovasc Med. 2025 May 1;12:1582049. doi: 10.3389/fcvm.2025.1582049. eCollection 2025.
6
High-Intensity Training on Patients with Hypertrophic Cardiomyopathy: A Systematic Review.肥厚型心肌病患者的高强度训练:一项系统评价
Egypt Heart J. 2025 May 15;77(1):45. doi: 10.1186/s43044-025-00642-2.
7
Revisiting Secondary Dilative Cardiomyopathy.再探继发性扩张型心肌病
Int J Mol Sci. 2025 Apr 28;26(9):4181. doi: 10.3390/ijms26094181.
8
Cardiac Fibroblasts: Helping or Hurting.心脏成纤维细胞:助力还是伤害?
Genes (Basel). 2025 Mar 27;16(4):381. doi: 10.3390/genes16040381.
9
Increased risk of cardiomyopathy in individuals with methamphetamine related disorders in Taiwan.台湾地区患有甲基苯丙胺相关障碍的个体患心肌病风险增加。
Sci Rep. 2025 Apr 3;15(1):11449. doi: 10.1038/s41598-025-94591-0.
10
A New Perspective on the Role of Alterations in Mitochondrial Proteins Involved in ATP Synthesis and Mobilization in Cardiomyopathies.关于参与心肌病中ATP合成与转运的线粒体蛋白改变作用的新视角
Int J Mol Sci. 2025 Mar 19;26(6):2768. doi: 10.3390/ijms26062768.